节点文献

1例曲妥珠单抗导致的心脏毒性病例分析

Case analysis on cardiotoxicity of trastuzumab

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 刘倩欣向倩李晓颖赵楠崔一民

【Author】 LIU Qian-xin;XIANG Qian;LI Xiao-ying;ZHAO Nan;CUI Yi-min;Department of Pharmacy, The First Hospital of Peking University;Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Science, Peking University;Department of Radiotherapy, The First Hospital of Peking University;

【机构】 北京大学第一医院药剂科北京大学药学院药事管理与临床药学系北京大学第一医院放疗科

【摘要】 抗肿瘤药物在肿瘤治疗中起到重要作用,但同时具有一定的潜在心脏毒性。抗肿瘤药物对心脏有多种损害机制及不同临床表现,对患者的生存和预后有着明显影响。心脏毒性可表现为心衰,心肌缺血,心律失常和高血压等。心脏毒性的危险因素包括年龄、放疗史、既往心脏病史以及与其他心脏毒性药物联用等。防治方法包括用药前评估,优化用药方式及定期检测等。

【Abstract】 Antitumor drugs play an important role in the tumor treatment, but also have certain cardiotoxic side effects. Antitumor drugs have a variety of damage mechanism on the heart and different clinical manifestations, which have obvious effects on prognosis and survival. Cardiotoxicity can manifest in many ways, such as heart failure, myocardial ischemia, arrhythmia and high blood pressure. Common factors increasing a patient’s risk of developing cardiotoxicity include age, history of radiotherapy, previous history of heart disease and combination with other cardiotoxic drugs. Prevention and treatment of these toxicities include evaluation before medication, optimal medication method, and regular inspection and so on.

【关键词】 肿瘤抗肿瘤药物靶向治疗心脏毒性
【Key words】 tumorantitumor drugstargeted therapycardiotoxicity
  • 【文献出处】 临床药物治疗杂志 ,Clinical Medication Journal , 编辑部邮箱 ,2016年05期
  • 【分类号】R979.1
  • 【被引频次】2
  • 【下载频次】228
节点文献中: 

本文链接的文献网络图示:

本文的引文网络